HEADER PEPTIDE BINDING PROTEIN 19-DEC-12 4IHL
TITLE HUMAN 14-3-3 ISOFORM ZETA IN COMPLEX WITH A DIPHOYPHORYLATED C-RAF
TITLE 2 PEPTIDE AND COTYLENIN A
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: 14-3-3 PROTEIN ZETA/DELTA;
COMPND 3 CHAIN: A, B;
COMPND 4 FRAGMENT: UNP RESIDUES 1-230;
COMPND 5 SYNONYM: PROTEIN KINASE C INHIBITOR PROTEIN 1, KCIP-1;
COMPND 6 ENGINEERED: YES;
COMPND 7 MOL_ID: 2;
COMPND 8 MOLECULE: RAF PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE;
COMPND 9 CHAIN: P;
COMPND 10 FRAGMENT: UNP RESIDUES 229-264;
COMPND 11 SYNONYM: PROTO-ONCOGENE C-RAF, CRAF, RAF-1;
COMPND 12 EC: 2.7.11.1;
COMPND 13 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: YWHAZ;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA (DE3);
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPROEX HTB;
SOURCE 11 MOL_ID: 2;
SOURCE 12 SYNTHETIC: YES;
SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 14 ORGANISM_COMMON: HUMAN;
SOURCE 15 ORGANISM_TAXID: 9606;
SOURCE 16 OTHER_DETAILS: SYNTHETIC PEPTIDE, THE FULL-LENTH C-RAF KINASE OCCURS
SOURCE 17 IN HOMO SPAIENS
KEYWDS 14-3-3 FOLD, RAF, ALL ALPHA-HELICAL, ADAPTER PROTEIN, PROTEIN-PROTEIN
KEYWDS 2 INTERACTION, PEPTIDE BINDING PROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR M.MOLZAN,C.OTTMANN
REVDAT 4 09-OCT-24 4IHL 1 REMARK
REVDAT 3 20-SEP-23 4IHL 1 COMPND REMARK SEQADV HETNAM
REVDAT 3 2 1 LINK
REVDAT 2 09-OCT-13 4IHL 1 JRNL
REVDAT 1 25-SEP-13 4IHL 0
JRNL AUTH M.MOLZAN,S.KASPER,L.ROGLIN,M.SKWARCZYNSKA,T.SASSA,T.INOUE,
JRNL AUTH 2 F.BREITENBUECHER,J.OHKANDA,N.KATO,M.SCHULER,C.OTTMANN
JRNL TITL STABILIZATION OF PHYSICAL RAF/14-3-3 INTERACTION BY
JRNL TITL 2 COTYLENIN A AS TREATMENT STRATEGY FOR RAS MUTANT CANCERS.
JRNL REF ACS CHEM.BIOL. V. 8 1869 2013
JRNL REFN ISSN 1554-8929
JRNL PMID 23808890
JRNL DOI 10.1021/CB4003464
REMARK 2
REMARK 2 RESOLUTION. 2.20 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.40
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3
REMARK 3 NUMBER OF REFLECTIONS : 42823
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.202
REMARK 3 R VALUE (WORKING SET) : 0.200
REMARK 3 FREE R VALUE : 0.243
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 2142
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26
REMARK 3 REFLECTION IN BIN (WORKING SET) : 2740
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.93
REMARK 3 BIN R VALUE (WORKING SET) : 0.2620
REMARK 3 BIN FREE R VALUE SET COUNT : 138
REMARK 3 BIN FREE R VALUE : 0.3410
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3762
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 90
REMARK 3 SOLVENT ATOMS : 294
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 48.79
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.15
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -1.22000
REMARK 3 B22 (A**2) : 3.55000
REMARK 3 B33 (A**2) : -2.33000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.192
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.178
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.126
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.988
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4076 ; 0.016 ; 0.022
REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5554 ; 1.575 ; 2.000
REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 514 ; 5.550 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 203 ;36.005 ;25.123
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 763 ;16.773 ;15.039
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 28 ;21.336 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 630 ; 0.103 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3022 ; 0.007 ; 0.020
REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN
REMARK 3 THE INPUT U VALUES : REFINED INDIVIDUALLY
REMARK 4
REMARK 4 4IHL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JAN-13.
REMARK 100 THE DEPOSITION ID IS D_1000076761.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 06-OCT-10
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 7.0
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SLS
REMARK 200 BEAMLINE : X10SA
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.9778
REMARK 200 MONOCHROMATOR : AL2/AL2
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : XSCALE, XDS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42870
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200
REMARK 200 RESOLUTION RANGE LOW (A) : 49.400
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3
REMARK 200 DATA REDUNDANCY : NULL
REMARK 200 R MERGE (I) : 0.03500
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.6500
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30
REMARK 200 COMPLETENESS FOR SHELL (%) : 97.5
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : 0.28000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.660
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIR
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: PDB ENTRY 4FJ3
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 66.37
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.66
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M NA-ACETATE PH 7.0, 0.8 M NAH2PO4
REMARK 280 AND 1.2 M K2HPO4, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.14000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.29000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.70000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 56.29000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.14000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 51.70000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 5030 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 22650 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, P
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A -4
REMARK 465 ALA A -3
REMARK 465 MET A -2
REMARK 465 GLY A -1
REMARK 465 SER A 0
REMARK 465 GLY B -4
REMARK 465 ALA B -3
REMARK 465 MET B -2
REMARK 465 GLY B -1
REMARK 465 SER B 0
REMARK 465 GLY B 71
REMARK 465 ALA B 72
REMARK 465 ASP B 136
REMARK 465 GLN P 229
REMARK 465 PHE P 238
REMARK 465 THR P 239
REMARK 465 PHE P 240
REMARK 465 ASN P 241
REMARK 465 THR P 242
REMARK 465 SER P 243
REMARK 465 SER P 244
REMARK 465 PRO P 245
REMARK 465 SER P 246
REMARK 465 SER P 247
REMARK 465 GLU P 248
REMARK 465 GLY P 249
REMARK 465 SER P 250
REMARK 465 LEU P 251
REMARK 465 SER P 252
REMARK 465 GLN P 253
REMARK 465 ARG P 254
REMARK 465 HIS P 264
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 GLN A 67 CG CD OE1 NE2
REMARK 470 LYS A 68 CG CD CE NZ
REMARK 470 GLU A 73 OE1 OE2
REMARK 470 LYS A 74 CE NZ
REMARK 470 LYS A 139 CE NZ
REMARK 470 LYS A 157 CD CE NZ
REMARK 470 LYS A 187 NZ
REMARK 470 MET B 1 CG SD CE
REMARK 470 LYS B 68 CG CD CE NZ
REMARK 470 GLU B 73 CG CD OE1 OE2
REMARK 470 LYS B 75 CG CD CE NZ
REMARK 470 LYS B 157 CE NZ
REMARK 470 GLU B 208 CG CD OE1 OE2
REMARK 470 GLU B 209 CG CD OE1 OE2
REMARK 470 SER B 230 OG
REMARK 470 ARG P 256 CD NE CZ NH1 NH2
REMARK 480
REMARK 480 ZERO OCCUPANCY ATOM
REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO
REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS
REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 480 M RES C SSEQI ATOMS
REMARK 480 GLU A 113 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION
REMARK 500 GLU A 113 CD GLU A 113 OE2 -0.181
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 SER A 184 68.61 -119.37
REMARK 500 ARG B 18 79.52 -109.01
REMARK 500
REMARK 500 REMARK: NULL
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 K A 301 K
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 ASP A 124 OD2
REMARK 620 2 HOH P 311 O 78.6
REMARK 620 N 1
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 K B 301 K
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 ASP B 124 OD2
REMARK 620 2 HOH P 313 O 83.4
REMARK 620 N 1
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE K A 301
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1F5 A 302
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE K B 301
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1F5 B 302
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1A4O RELATED DB: PDB
REMARK 900 14-3-3 PROTEIN ZETA ISOFORM
REMARK 900 RELATED ID: 1QJA RELATED DB: PDB
REMARK 900 14-3-3 ZETA/PHOSPHOPEPTIDE COMPLEX (MODE 2)
REMARK 900 RELATED ID: 1QJB RELATED DB: PDB
REMARK 900 14-3-3 ZETA/PHOSPHOPEPTIDE COMPLEX (MODE 1)
REMARK 900 RELATED ID: 1IB1 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF THE 14-3-3 ZETA:SEROTONIN N-ACETYLTRANSFERASE
REMARK 900 COMPLEX
REMARK 900 RELATED ID: 4FJ3 RELATED DB: PDB
REMARK 900 14-3-3 ISOFORM ZETA IN COMPLEX WITH A DIPHOYPHORYLATED C-RAF PEPTIDE
REMARK 900 RELATED ID: 3E6Y RELATED DB: PDB
REMARK 900 STRUCTURE OF 14-3-3 IN COMPLEX WITH THE DIFFERENTIATION-INDUCING
REMARK 900 AGENT COTYLENIN A
REMARK 900 RELATED ID: 3SMK RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA C38V/N166H IN COMPLEX WITH
REMARK 900 TASK-3 PEPTIDE AND STABILIZER COTYLENIN A
REMARK 900 RELATED ID: 4IEA RELATED DB: PDB
DBREF 4IHL A 1 230 UNP P63104 1433Z_HUMAN 1 230
DBREF 4IHL B 1 230 UNP P63104 1433Z_HUMAN 1 230
DBREF 4IHL P 229 264 UNP P04049 RAF1_HUMAN 229 264
SEQADV 4IHL GLY A -4 UNP P63104 EXPRESSION TAG
SEQADV 4IHL ALA A -3 UNP P63104 EXPRESSION TAG
SEQADV 4IHL MET A -2 UNP P63104 EXPRESSION TAG
SEQADV 4IHL GLY A -1 UNP P63104 EXPRESSION TAG
SEQADV 4IHL SER A 0 UNP P63104 EXPRESSION TAG
SEQADV 4IHL GLY B -4 UNP P63104 EXPRESSION TAG
SEQADV 4IHL ALA B -3 UNP P63104 EXPRESSION TAG
SEQADV 4IHL MET B -2 UNP P63104 EXPRESSION TAG
SEQADV 4IHL GLY B -1 UNP P63104 EXPRESSION TAG
SEQADV 4IHL SER B 0 UNP P63104 EXPRESSION TAG
SEQRES 1 A 235 GLY ALA MET GLY SER MET ASP LYS ASN GLU LEU VAL GLN
SEQRES 2 A 235 LYS ALA LYS LEU ALA GLU GLN ALA GLU ARG TYR ASP ASP
SEQRES 3 A 235 MET ALA ALA CYS MET LYS SER VAL THR GLU GLN GLY ALA
SEQRES 4 A 235 GLU LEU SER ASN GLU GLU ARG ASN LEU LEU SER VAL ALA
SEQRES 5 A 235 TYR LYS ASN VAL VAL GLY ALA ARG ARG SER SER TRP ARG
SEQRES 6 A 235 VAL VAL SER SER ILE GLU GLN LYS THR GLU GLY ALA GLU
SEQRES 7 A 235 LYS LYS GLN GLN MET ALA ARG GLU TYR ARG GLU LYS ILE
SEQRES 8 A 235 GLU THR GLU LEU ARG ASP ILE CYS ASN ASP VAL LEU SER
SEQRES 9 A 235 LEU LEU GLU LYS PHE LEU ILE PRO ASN ALA SER GLN ALA
SEQRES 10 A 235 GLU SER LYS VAL PHE TYR LEU LYS MET LYS GLY ASP TYR
SEQRES 11 A 235 TYR ARG TYR LEU ALA GLU VAL ALA ALA GLY ASP ASP LYS
SEQRES 12 A 235 LYS GLY ILE VAL ASP GLN SER GLN GLN ALA TYR GLN GLU
SEQRES 13 A 235 ALA PHE GLU ILE SER LYS LYS GLU MET GLN PRO THR HIS
SEQRES 14 A 235 PRO ILE ARG LEU GLY LEU ALA LEU ASN PHE SER VAL PHE
SEQRES 15 A 235 TYR TYR GLU ILE LEU ASN SER PRO GLU LYS ALA CYS SER
SEQRES 16 A 235 LEU ALA LYS THR ALA PHE ASP GLU ALA ILE ALA GLU LEU
SEQRES 17 A 235 ASP THR LEU SER GLU GLU SER TYR LYS ASP SER THR LEU
SEQRES 18 A 235 ILE MET GLN LEU LEU ARG ASP ASN LEU THR LEU TRP THR
SEQRES 19 A 235 SER
SEQRES 1 B 235 GLY ALA MET GLY SER MET ASP LYS ASN GLU LEU VAL GLN
SEQRES 2 B 235 LYS ALA LYS LEU ALA GLU GLN ALA GLU ARG TYR ASP ASP
SEQRES 3 B 235 MET ALA ALA CYS MET LYS SER VAL THR GLU GLN GLY ALA
SEQRES 4 B 235 GLU LEU SER ASN GLU GLU ARG ASN LEU LEU SER VAL ALA
SEQRES 5 B 235 TYR LYS ASN VAL VAL GLY ALA ARG ARG SER SER TRP ARG
SEQRES 6 B 235 VAL VAL SER SER ILE GLU GLN LYS THR GLU GLY ALA GLU
SEQRES 7 B 235 LYS LYS GLN GLN MET ALA ARG GLU TYR ARG GLU LYS ILE
SEQRES 8 B 235 GLU THR GLU LEU ARG ASP ILE CYS ASN ASP VAL LEU SER
SEQRES 9 B 235 LEU LEU GLU LYS PHE LEU ILE PRO ASN ALA SER GLN ALA
SEQRES 10 B 235 GLU SER LYS VAL PHE TYR LEU LYS MET LYS GLY ASP TYR
SEQRES 11 B 235 TYR ARG TYR LEU ALA GLU VAL ALA ALA GLY ASP ASP LYS
SEQRES 12 B 235 LYS GLY ILE VAL ASP GLN SER GLN GLN ALA TYR GLN GLU
SEQRES 13 B 235 ALA PHE GLU ILE SER LYS LYS GLU MET GLN PRO THR HIS
SEQRES 14 B 235 PRO ILE ARG LEU GLY LEU ALA LEU ASN PHE SER VAL PHE
SEQRES 15 B 235 TYR TYR GLU ILE LEU ASN SER PRO GLU LYS ALA CYS SER
SEQRES 16 B 235 LEU ALA LYS THR ALA PHE ASP GLU ALA ILE ALA GLU LEU
SEQRES 17 B 235 ASP THR LEU SER GLU GLU SER TYR LYS ASP SER THR LEU
SEQRES 18 B 235 ILE MET GLN LEU LEU ARG ASP ASN LEU THR LEU TRP THR
SEQRES 19 B 235 SER
SEQRES 1 P 36 GLN HIS ARG TYR SEP THR PRO HIS ALA PHE THR PHE ASN
SEQRES 2 P 36 THR SER SER PRO SER SER GLU GLY SER LEU SER GLN ARG
SEQRES 3 P 36 GLN ARG SER THR SEP THR PRO ASN VAL HIS
MODRES 4IHL SEP P 233 SER PHOSPHOSERINE
MODRES 4IHL SEP P 259 SER PHOSPHOSERINE
HET SEP P 233 10
HET SEP P 259 10
HET K A 301 1
HET 1F5 A 302 44
HET K B 301 1
HET 1F5 B 302 44
HETNAM SEP PHOSPHOSERINE
HETNAM K POTASSIUM ION
HETNAM 1F5 (1R,3AS,4R,5R,6R,9AR,10E)-6-({(1S,2R,4S,5R,6R,8S,9S)-5-
HETNAM 2 1F5 HYDROXY-2-(METHOXYMETHYL)-9-METHYL-9-[(2S)-OXIRAN-2-
HETNAM 3 1F5 YL]-3,7,10,1 1-TETRAOXATRICYCLO[6.2.1.0~1,6~]UNDEC-4-
HETNAM 4 1F5 YL}OXY)-1-(METHOXYMETHYL)-4,9A-DIMETHYL-7-(PROPAN-2-
HETNAM 5 1F5 YL)-1,2,3,3A,4,5,6,8,9,9A-DE CAHYDRODICYCLOPENTA[A,
HETNAM 6 1F5 D][8]ANNULENE-1,5-DIOL
HETSYN SEP PHOSPHONOSERINE
HETSYN 1F5 COTYLENIN A
FORMUL 3 SEP 2(C3 H8 N O6 P)
FORMUL 4 K 2(K 1+)
FORMUL 5 1F5 2(C33 H50 O11)
FORMUL 8 HOH *294(H2 O)
HELIX 1 1 MET A 1 ALA A 16 1 16
HELIX 2 2 ARG A 18 GLN A 32 1 15
HELIX 3 3 SER A 37 LYS A 68 1 32
HELIX 4 4 ALA A 72 PHE A 104 1 33
HELIX 5 5 PHE A 104 ALA A 109 1 6
HELIX 6 6 GLN A 111 GLU A 131 1 21
HELIX 7 7 ASP A 136 MET A 160 1 25
HELIX 8 8 HIS A 164 LEU A 182 1 19
HELIX 9 9 SER A 184 GLU A 202 1 19
HELIX 10 10 LEU A 203 LEU A 206 5 4
HELIX 11 11 SER A 210 SER A 230 1 21
HELIX 12 12 ASP B 2 ALA B 16 1 15
HELIX 13 13 ARG B 18 GLN B 32 1 15
HELIX 14 14 SER B 37 LYS B 68 1 32
HELIX 15 15 LYS B 74 PHE B 104 1 31
HELIX 16 16 PHE B 104 ALA B 109 1 6
HELIX 17 17 GLN B 111 VAL B 132 1 22
HELIX 18 18 LYS B 138 MET B 160 1 23
HELIX 19 19 HIS B 164 ILE B 181 1 18
HELIX 20 20 SER B 184 ALA B 201 1 18
HELIX 21 21 GLU B 202 LEU B 206 5 5
HELIX 22 22 SER B 210 SER B 230 1 21
LINK C TYR P 232 N SEP P 233 1555 1555 1.34
LINK C SEP P 233 N THR P 234 1555 1555 1.33
LINK C THR P 258 N SEP P 259 1555 1555 1.33
LINK C SEP P 259 N THR P 260 1555 1555 1.34
LINK OD2 ASP A 124 K K A 301 1555 1555 3.22
LINK K K A 301 O HOH P 311 1555 1555 2.51
LINK OD2 ASP B 124 K K B 301 1555 1555 3.07
LINK K K B 301 O HOH P 313 1555 1555 2.50
CISPEP 1 ALA A 134 GLY A 135 0 -10.60
SITE 1 AC1 2 ASP A 124 HOH P 311
SITE 1 AC2 11 ASN A 42 PHE A 117 LYS A 120 MET A 121
SITE 2 AC2 11 PRO A 165 ASP A 213 HOH A 513 HOH A 537
SITE 3 AC2 11 THR P 260 PRO P 261 VAL P 263
SITE 1 AC3 2 ASP B 124 HOH P 313
SITE 1 AC4 13 ASN B 42 LEU B 43 PHE B 117 LYS B 120
SITE 2 AC4 13 MET B 121 PRO B 165 ASP B 213 HOH B 417
SITE 3 AC4 13 HOH B 420 HOH B 427 THR P 234 PRO P 235
SITE 4 AC4 13 ALA P 237
CRYST1 72.280 103.400 112.580 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.013835 0.000000 0.000000 0.00000
SCALE2 0.000000 0.009671 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008883 0.00000